Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DYNAVAX TECHNOLOGIES CORP Director's Dealing 2021

Mar 2, 2021

32130_dirs_2021-03-02_d8fdf664-aee5-4281-a4a0-4f6fd58e0c31.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2021-03-01

Reporting Person: MacDonald Kelly (SVP and CFO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-01 Stock Option (Right to Buy) $8.90 A 350000 Acquired 2028-02-29 Common Stock (350000) Direct

Footnotes

F1: This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of March 1, 2021, and one thirty-sixth (1/36) of the shares
subject to the option vesting each month thereafter.